http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001051106-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_070bf8e18ff85bc6a966038d320ef0b5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34
filingDate 2001-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b43baebcf1b511628b4ca3b2e2166d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adbde7b4e0d022079d59a9bf9ad67854
publicationDate 2001-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2001051106-A1
titleOfInvention Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
abstract A hemofiltration system for a mammal comprises a hemofilter and an adsorbent device. The hemofilter removes ultrafiltrate from a blood stream extracted from the mammal to create a filtered blood stream and an ultrafiltrate stream. The adsorbent device is comprised of one or more adsorbent materials and is used to adsorb inflammatory mediators from the ultrafiltrate stream received from the hemofilter removing inflammatory mediators that cause inflammatory mediator related disease, sepsis, and SIRS/MODS/MOSF to create a post adsorption ultrafiltrate stream. The post adsorption ultrafiltrate stream is selectively combined with the filtered blood stream and together with the filtered blood stream is returned to the mammal.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7837878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008110830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010241044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007218-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007218-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009204050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1545690-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1951337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011040228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004228829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7520992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7758533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292627-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7524420-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011004142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8647291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006163138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006129082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1545690-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004173530-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018093032-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010288761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8747342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007049286-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8597516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1951337-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8708943-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007092509-A1
priorityDate 1998-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5571418-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6287516-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135452479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861

Total number of triples: 51.